Truth in clinical research trials involving pharmaceutical sponsorship.
Large clinical trials are expensive to mount. Funding comes mainly from pharmaceutical companies seeking information on drug efficacy and adverse events. Patients should be informed of the financial and publication agreements reached between those conducting the trials. This is unlikely to have a significant effect on trial participation and will provide patients with information relevant to informed consent. A small proportion of monies raised from drug trials could be set aside to fund both a trial register site and further studies on adverse drug reactions.
Commens
C A
CA
Department of Dermatology, Westmead Hospital, Sydney, NSW. ccommens@mail.usyd.edu.au
D015982:Bias; D002986:Clinical Trials as Topic / Q000592:standards*; D004345:Drug Industry; D006801:Humans; D007258:Informed Consent; D018973:Intellectual Property; D010344:Patient Advocacy; D010353:Patient Education as Topic; D012109:Research Support as Topic / Q000458:organization & administration*; D014342:Truth Disclosure